Jerome B Riebman
Physician in Basking Ridge, NJ
License number
Utah 173965-1205
Issued Date
Oct 10, 1985
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician & Surgeon
Address
Address
Basking Ridge, NJ
Professional information
Fenestrated Hemostatic Patch
US Patent:
2013008, Apr 4, 2013
Filed:
Sep 25, 2012
Appl. No.:
13/625968
Inventors:
Jerome Riebman - Basking Ridge NJ, US
Jeffrey Hammond - Bernardsville NJ, US
Kevin Weadock - Hillsborough NJ, US
John P. Matonick - Warren NJ, US
Jeffrey Hammond - Bernardsville NJ, US
Kevin Weadock - Hillsborough NJ, US
John P. Matonick - Warren NJ, US
International Classification:
A61K 9/70, A61F 13/02, C07K 14/78, A61K 38/39, A61P 7/04
US Classification:
424444, 514 137, 530356, 424400, 427 231
Abstract:
A hemostat comprises a non-porous patch made of a bio-resorbable tissue compatible material, said patch having a tissue-facing surface and a top surface; an optional hemostatic agent that is disposed on said tissue-facing surface or optionally dispersed throughout said patch or optionally as a separate carrier layer, and at least one aperture or slit that penetrates said patch at least partially from said tissue-facing surface to said top surface.
Dressing Device
US Patent:
2013013, May 23, 2013
Filed:
Nov 17, 2011
Appl. No.:
13/298495
Inventors:
Robert W. Van Holten - Flemington NJ, US
Xintian Ming - Bridgewater NJ, US
Jerome Riebman - Basking Ridge NJ, US
Xintian Ming - Bridgewater NJ, US
Jerome Riebman - Basking Ridge NJ, US
International Classification:
A61F 13/53, A61K 31/08, A61P 17/02, A01N 25/08, A01P 1/00, A61K 9/70, A01N 47/44
US Classification:
604368, 424445, 514723, 514635, 424409
Abstract:
The invention relates to a transparent, absorbent device for the dressing of wounds and insertion sites of percutaneous and drug delivery devices. The device provides 360 degree or complete circumferential protection of a wound or insertion site of a percutaneous or drug delivery device and comprises a hydrogel center and at least one absorbent material. The hydrogel center can optionally comprise a bioactive agent(s).